In response to the COVID-19 pandemic, the Heart Rhythm Society (HRS) led a global cross-sectional survey of more than 1,100 electrophysiologists (EPs) to better understand the prevalence of cardiac arrhythmias and treatment strategies in hospitalized COVID-19 patients.
A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or paroxysmal atrial fibrillation (AF) and showcases a novel approach to performing point-by-point ablation to provide safe and effective patient outcomes.
A new clinical study found that patients with atrial fibrillation (AF) experienced a high incidence of clinically silent brain infarcts, despite taking oral anticoagulants for stroke prevention. Silent brain infarcts were significantly associated with cognitive decline.
Results of a clinical trial released today show stark disparities in the use of life-saving implantable cardiverter defibrillator (ICD) interventions based on sex and race, suggesting potential bias in care pathways by electrophysiologists (EPs).
A new study reveals that drinking a couple of daily cups of coffee does not lead to a greater risk of arrhythmias, potentially debunking a common myth that consuming caffeine in coffee and other drinks could lead to a faster heartbeat and the potential for a triggered arrhythmia for this patient
The Heart Rhythm Society (HRS) released a white paper announcing the rationale and core components for Atrial Fibrillation (AF) Centers of Excellence (CoE), to provide multidisciplinary care for AF patients.
Potential for unintended temporary programming and arrhythmic complications when an electronic cigarette is placed in close proximity to an implantable cardioverter-defibrillator or pacemaker reported in HeartRhythm Case Reports.